Use of polymer d-lactic acid (pdla) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers
AssigneeThe United States of America as represented by the Department of Veterans Affairs
InventorsJoel S. Goldberg, Joe Brice Weinberg
Life of this patent
Estimating the term…
Abstract
The invention provides method for sequestering or trapping L-lactate in or near a tumor cell comprising contacting an isolated polymer of D-lactic acid (PDLA) or an equivalent, derivative or analog thereof with the tumor cell so that the PDLA binds L-lactate in or near the cell and thereby sequestering or trapping L-lactate in or near the tumor cells.
Claims11
1-13. (canceled)
A composition comprising isolated PDLA or an equivalent, derivative or analog thereof having a molecular weight (MW) of less than 500 Daltons, wherein the composition is substantially free of PDLA having a MW greater than 500 Daltons.
A composition comprising isolated PDLA or an equivalent, derivative or analog thereof having fewer than 12 monomers of D-lactic acid, wherein the composition is substantially free of PDLA having more than 12 monomers of D-lactic acid.
A kit for sequestering, depleting, measuring, or detecting L-lactic acid in solution, in cell culture, in serum, in a cell, or in an animal comprising PDLA or an equivalent, derivative or analog thereof either unmodified or modified.
22-40. (canceled)
Dependencies are inferred from the claim text.